RU93046328A - INJECTION PRODUCT FOR HEMOCORRECTION - Google Patents

INJECTION PRODUCT FOR HEMOCORRECTION

Info

Publication number
RU93046328A
RU93046328A RU93046328/14A RU93046328A RU93046328A RU 93046328 A RU93046328 A RU 93046328A RU 93046328/14 A RU93046328/14 A RU 93046328/14A RU 93046328 A RU93046328 A RU 93046328A RU 93046328 A RU93046328 A RU 93046328A
Authority
RU
Russia
Prior art keywords
hemocorrection
injection product
relates
myelopoiesis
hemo
Prior art date
Application number
RU93046328/14A
Other languages
Russian (ru)
Other versions
RU2094438C1 (en
Inventor
А.В. Асафов
В.В. Безюлев
И.Д. Трещалин
Э.Р. Переверзева
Д.А. Бодягин
Original Assignee
Научно-производственное предприятие "Фармэк"
Filing date
Publication date
Application filed by Научно-производственное предприятие "Фармэк" filed Critical Научно-производственное предприятие "Фармэк"
Priority claimed from RU93046328/14A external-priority patent/RU2094438C1/en
Priority to RU93046328/14A priority Critical patent/RU2094438C1/en
Priority to JP7500517A priority patent/JP2772140B2/en
Priority to DE69429812T priority patent/DE69429812T2/en
Priority to EP94913856A priority patent/EP0712936B1/en
Priority to PCT/RU1994/000084 priority patent/WO1994028153A2/en
Priority to AU65849/94A priority patent/AU6584994A/en
Priority to AT94913856T priority patent/ATE212848T1/en
Priority to ES94913856T priority patent/ES2171450T3/en
Publication of RU93046328A publication Critical patent/RU93046328A/en
Publication of RU2094438C1 publication Critical patent/RU2094438C1/en
Application granted granted Critical

Links

Claims (1)

Изобретение относится к медицине, в частности к фармакологии и фармации, и касается средств для коррекции гемопоэза при его нарушениях, вызванных различными факторами. Предложено средство, содержащее натриевую соль ДНК и фармацевтически адекватный растворитель при определенных соотношениях компонентов. Средство стимулирует гемо- и миелопоэз, не вызывает осложнений.The invention relates to medicine, in particular to pharmacology and pharmacy, and relates to means for the correction of hematopoiesis in case of its disorders caused by various factors. The proposed tool containing sodium salt of DNA and a pharmaceutically adequate solvent in certain proportions of the components. The tool stimulates hemo- and myelopoiesis, does not cause complications.
RU93046328/14A 1993-05-24 1993-10-11 Injection agent for hemocorrection RU2094438C1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
RU93046328/14A RU2094438C1 (en) 1993-10-11 1993-10-11 Injection agent for hemocorrection
PCT/RU1994/000084 WO1994028153A2 (en) 1993-05-24 1994-04-14 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
DE69429812T DE69429812T2 (en) 1993-05-24 1994-04-14 LOW-MOLECULAR DNA FROM STUNNED MILK, METHOD FOR THE DETERMINATION OF THE DNA AND A PHARMACEUTICAL PREPARATION BASED ON IT
EP94913856A EP0712936B1 (en) 1993-05-24 1994-04-14 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
JP7500517A JP2772140B2 (en) 1993-05-24 1994-04-14 Low molecular weight deoxyribonucleic acid (DNA) of sturgeon fish sperm, method for extracting the DNA, and pharmaceutical preparation based on the DNA
AU65849/94A AU6584994A (en) 1993-05-24 1994-04-14 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
AT94913856T ATE212848T1 (en) 1993-05-24 1994-04-14 LOW MOLECULAR DNA FROM STURGEON MILK, METHOD FOR OBTAINING DNA AND A PHARMACEUTICAL PREPARATION BASED THEREOF
ES94913856T ES2171450T3 (en) 1993-05-24 1994-04-14 LOW-MOLECULAR WEIGHT DNA FROM STURION DATE, PROCEDURE FOR OBTAINING DNA AND PHARMACEUTICAL PREPARATION BASED ON THE SAME.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93046328/14A RU2094438C1 (en) 1993-10-11 1993-10-11 Injection agent for hemocorrection

Publications (2)

Publication Number Publication Date
RU93046328A true RU93046328A (en) 1996-10-10
RU2094438C1 RU2094438C1 (en) 1997-10-27

Family

ID=20147902

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93046328/14A RU2094438C1 (en) 1993-05-24 1993-10-11 Injection agent for hemocorrection

Country Status (1)

Country Link
RU (1) RU2094438C1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2200008C1 (en) * 2001-08-09 2003-03-10 Мельников Дмитрий Юрьевич Method for treating the cases of generalized tumor development processes
RU2336899C1 (en) * 2007-03-05 2008-10-27 ГУ Научно-исследовательский институт фармакологии Томского научного центра Сибирского отделения Российской академии медицинских наук ГУ НИИ фармакологии ТНЦ СО РАМН Method of myelopoiesis stimulation
RU2366452C1 (en) * 2008-04-28 2009-09-10 Государственное учреждение Научно-исследовательский институт фармакологии Томского научного центра Сибирского отделения Российской Академии медицинских наук (ГУ НИИ фармакологии ТНЦ СО РАМН) Method of myelopoiesis stimulation

Similar Documents

Publication Publication Date Title
RU94004977A (en) COMPOUNDS WITH SULFEMOIL AND AMIDINO-GROUP, METHOD OF THEIR RECEIVING AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
RU93005350A (en) NEW SUBSTITUTED PHENYLIMIDAZOLIDINES, METHOD FOR THEIR PRODUCTION, THEIR USE AS MEDICINES AND INCLUDING THEIR PHARMACEUTICAL COMPOUNDS
HUT69284A (en) Novel benzoyl amino acid derivs., pharmaceutical compns. conth. them and process to prepare them
RU93045710A (en) ANTIVIRAL NUCLEOSIDE COMPOSITION, METHOD OF ITS PRODUCTION AND METHOD OF TREATMENT
NO305603B1 (en) 2,6-diaminopurine derivatives, their use as well as pharmaceutical mixture
FI951681A7 (en) Substituted N-heteroaroylguanidines, a process for their preparation, their use as pharmaceuticals or diagnostic agents, and a pharmaceutical composition containing them
DE69603240D1 (en) NEW DEAZAPORE DERIVATIVES; A NEW CLASS OF CRF1-SPECIFIC LIGANDS
CO4440626A1 (en) THERAPEUTIC AMIDES
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
EP0372466A3 (en) 2-amino-4 or 5-methoxycyclohexyl amides useful as analgesics
RU93004445A (en) NEW 2-CYANO 3-HYDROXYENAMIDE DERIVATIVES, METHOD FOR THEIR RECEPTION, THEIR APPLICATION AS MEDICATION, CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS AND NEW OBTAINED INTERMEDIATE
GR3018009T3 (en) Use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism, and the compositions obtained.
HUT58764A (en) Process for producing peptides, pharmaceutical compositions containing them and amino-acid intermediates
FI935617A7 (en) 3,5-substituted aminobenzoylguanidines, a process for their preparation, their use as pharmaceuticals or diagnostic agents, and a pharmaceutical containing them
GR3018967T3 (en) Supersaturated topical compositions.
RU94002133A (en) 6-CHLOR-5-FTOR-3- (2-TENOIL) -2-OXINDOL-1-CARBOXAMIDE AS AN ANALOGESIC AND ANIMATERATIVE MEDICATION
ZA865696B (en) Peptide amino-alcohol derivatives containing a tetrasubstituted carbon atom,inhibiting renin and acid proteases,process for obtention and therapeutical use
IL101887A0 (en) Heterocyclic carboxylic acids and their preparation
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
RU93046328A (en) INJECTION PRODUCT FOR HEMOCORRECTION
FR2675804B1 (en) PROCESS FOR THE SYNTHESIS OF PEPTIDES, NOVEL AMINO ACID DERIVATIVES USED IN THIS PROCESS AND THEIR PREPARATION METHODS.
HU9601977D0 (en) Mixtures containing amino acides and dipeptides, process for producing the dipeptides, and pharmaceutical compositions containing these mixtures and/or dipeptides
DE3361591D1 (en) Polypeptides with an antagonistic activity on substance p, process for their preparation, their use and process for the purification of polypeptides
KR950703559A (en) Novel condensed thiazole derivative, process for producing the same, and pharmaceutical composition containing the same
GR3021472T3 (en) New peptide derivatives with bradykinin-antagonistic activity, process to prepare them and pharmaceutical compositions containing them.